The influence of surface modification on the cytotoxicity of PAMAM dendrimers

被引:591
作者
Jevprasesphant, R [1 ]
Penny, J [1 ]
Jalal, R [1 ]
Attwood, D [1 ]
McKeown, NB [1 ]
D'Emanuele, A [1 ]
机构
[1] Univ Manchester, Dept Chem, Manchester M13 9PL, Lancs, England
关键词
dendrimers; PAMAM; surface modification; cytotoxicity; viability; Caco-2; cells; lauroyl chloride; polyethylene glycol;
D O I
10.1016/S0378-5173(02)00623-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influence of surface modification on the cytotoxicity of PAMAM dendrimers was examined using Caco-2 cells. Dendrimers were modified by conjugating either lauroyl chains or polyethylene glycol (PEG) 2000 onto the surface of cationic PAMAM dendrimers (G2, G3, G4). The cytotoxicity of unmodified dendrimers towards Caco-2 cells was appreciably higher for cationic (whole generation) compared with anionic (half generation) dendrimers and for both types increased with increasing size (generation) and concentration. A marked decrease in the cytotoxicity of cationic PAMAM dendrimers was noted when the surface was modified, with the addition of six lauroyl or four PEG chains being particularly effective in decreasing cytotoxicity. This decrease in cytotoxicity is thought to be due to a reduction/shielding of the positive charge on the dendrimer surface by the attached chains. The cytotoxicity of dendrimer-based delivery systems is likely to be very different from the parent dendrimer. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 10 条
[1]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[2]   In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery [J].
Brazeau, GA ;
Attia, S ;
Poxon, S ;
Hughes, JA .
PHARMACEUTICAL RESEARCH, 1998, 15 (05) :680-684
[3]  
DEMANUELE A, 2002, ENCY PHARM TECHNOLOG
[4]   Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers [J].
El-Sayed, M ;
Ginski, M ;
Rhodes, C ;
Ghandehari, H .
JOURNAL OF CONTROLLED RELEASE, 2002, 81 (03) :355-365
[5]   Dendrimers:: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo [J].
Malik, N ;
Wiwattanapatapee, R ;
Klopsch, R ;
Lorenz, K ;
Frey, H ;
Weener, JW ;
Meijer, EW ;
Paulus, W ;
Duncan, R .
JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) :133-148
[7]  
Roberts JC, 1996, J BIOMED MATER RES, V30, P53, DOI 10.1002/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO
[8]  
2-Q
[9]   DENDRIMER MOLECULES [J].
TOMALIA, DA .
SCIENTIFIC AMERICAN, 1995, 272 (05) :62-66
[10]   Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers [J].
Yoo, H ;
Juliano, RL .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4225-4231